Fragment screening purely with protein crystallography

Methods in Enzymology

Volumn 493, Issue , 2011, Pages 321-356

  Spurlino, John C ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN 4; LIQUID NITROGEN;

ARTICLE; BINDING AFFINITY; COMPUTER PROGRAM; DRUG DESIGN; DRUG SCREENING; ELECTRON; FRAGMENTATION REACTION; GENERATOR; HIGH THROUGHPUT SCREENING; INFORMATION PROCESSING; METHODOLOGY; MOLECULAR PROBE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; ROBOTICS; SCREENING TEST; SYNCHROTRON; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION;

EID: 79952392408     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381274-2.00013-3     Document Type: Chapter

References (42)

1. P.D. Adams PHENIX: Building new software for automated crystallographic structure determination Acta Crystallogr. D 58 2002 1948 1954 (Pubitemid 35337293)
2. P.D. Adams PHENIX: A comprehensive Python-based system for macromolecular structure solution Acta Crystallogr. D 66 2010 213 221
3. S.S. Antonysamy Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors Bioorg. Med. Chem. Lett. 18 2008 2990 2995 (Pubitemid 351608863)
4. T.L. Blundell Structural biology and bioinformatics in drug design: Opportunities and challenges for target identification and lead discovery Philos. Trans. R. Soc. B Biol. Sci. 361 2006 413 423 (Pubitemid 44870098)
5. V.B. Chen MolProbity: All-atom structure validation for macromolecular crystallography Acta Crystallogr. D 66 2010 12 21
6. M. Congreve A [']Rule of Three' for fragment-based lead discovery? Drug Discov. Today 8 2003 876 877 (Pubitemid 37194496)
7. D.R. Davies Discovery of leukotriene A4 hydrolase Inhibitors using metabolomics biased fragment crystallography J. Med. Chem. 52 2009 4694 4715
8. W.L. DeLano The PyMOL Molecular Graphics System 2008 DeLano Scientific LLC Palo Alto, CA, USA
9. P. Emsley, and K. Cowtan Coot: Model-building tools for molecular graphics Acta Crystallogr. D 60 2004 2126 2132 (Pubitemid 41742764)
10. M. Furuhashi, and G.S. Hotamisligil Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets Nat. Rev. Drug Discov. 7 2008 489 503 (Pubitemid 351767117)
11. M. Furuhashi Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 Nature 447 2007 959 965 (Pubitemid 46975747)
12. P.J. Hajduk, and J. Greer A decade of fragment-based drug design: Strategic advances and lessons learned Nat. Rev. Drug Discov. 6 2007 211 219 (Pubitemid 46344625)
13. P.J. Hajduk Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR J. Am. Chem. Soc. 119 1997 5818 5827 (Pubitemid 27305763)
14. M.M. Hann Molecular complexity and its impact on the probability of finding leads for drug discovery J. Chem. Inf. Comput. Sci. 41 2001 856 864
15. M.J. Hartshorn Fragment-based lead discovery using X-ray crystallography J. Med. Chem. 48 2005 403 413 (Pubitemid 40139783)
16. J. Holton, and T. Alber Automated protein crystal structure determination using elves Proc. Natl. Acad. Sci. USA 101 2004 1537 1542 (Pubitemid 38234190)
17. IMCA https://www.imca.aps.anl.gov/tiki-index.php?page=IMCA Accessed on 12/11/10
18. W. Kabsch Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants J. Appl. Crystallogr. 26 1993 795 800
19. M. Kroemer APRVA program for automated data processing, refinement and visualization Acta Crystallogr. D 60 2004 1679 1682 (Pubitemid 41103555)
20. L.C. Kuo How to Avoid Rediscovering the Known Methods Enzymol 493 2011 159 168
21. J. Lanter, X. Zhang, and Z. Sui Medicinal Chemistry-Inspired Fragment-Based Drug Discovery Methods Enzymol 493 2011 423 448
22. C.A. Lipinski Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 46 2001 3 26 (Pubitemid 33653411)
23. J. Marchal, and A. Wagner Performance of PILATUS detector technology for long-wavelength macromolecular crystallography Nucl. Instrum. Methods Phys. Res. A 2010 doi:10.1016/j.nima.2010.06.142
24. M.L. Mohler Recent and emerging anti-diabetes targets Med. Res. Rev. 29 2009 125 195
25. S.W. Muchmore Automated crystal mounting and data collection for protein crystallography Structure 8 2000 R243 R246
26. C.W. Murray, and T.L. Blundell Structural biology in fragment-based drug design Curr. Opin. Struct. Biol. 20 2010 497 507
27. A. Nicholls Molecular shape and medicinal chemistry: A perspective J. Med. Chem. 53 2010 3862 3886
28. V.L. Nienaber Discovering novel ligands for macromolecules using X-ray crystallographic screening Nat. Biotechnol. 18 2000 1105 1108
29. Z. Otwinowski, and W. Minor Processing of X-ray diffraction data collected in oscillation mode C.W. Carter Jr. R.M. Sweet, Methods in Enzymology Vol. 276 1997 Academic Press, San Diego, CA 307 326 (Pubitemid 27085611)
30. J.W. Pflugrath The finer things in X-ray diffraction data collection Acta Crystallogr. D Biol. Crystallogr. 55 1999 1718 1725 (Pubitemid 29504426)
31. J.W. Pflugrath Macromolecular cryocrystallographyMethods for cooling and mounting protein crystals at cryogenic temperatures Methods 34 2004 415 423 (Pubitemid 39119822)
32. PXI http://sls.web.psi.ch/view.php/beamlines/px/index.html Accessed on 12/11/10
33. E.J. Rhee The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults Eur. J. Endocrinol. 160 2009 165 172
34. A. Schuffenhauer Library design for fragment based screening Curr. Top. Med. Chem. 5 2005 751 762 (Pubitemid 41179715)
35. R.F. Service Robots enter the race to analyze proteins Science 292 2001 187 188 (Pubitemid 32295352)
36. SGX. http://www.sgxpharma.com/. now part of Lilly
37. B.K. Shoichet Screening in a spirit haunted world Drug Discov. Today 11 2006 607 615
38. S.B. Shuker Discovering high-affinity ligands for proteins: SAR by NMR Science 274 1996 1531 1534 (Pubitemid 26403929)
39. B.O.V. Shum The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation J. Clin. Invest. 116 2006 2183 2192 (Pubitemid 44162327)
40. Tounge B.A., and Parker M.H. Designing a Diverse High-Quality Library for Crystallography-Based FBDD Screening Methods Enzymol 493 2011 3 20
41. K.E. Yun Association between adipocyte fatty acid-binding protein levels and childhood obesity in Korean children Metab. Clin. Exp. 58 2009 798 802
42. Zenobia http://www.zenobiatherapeutics.com/home-page.htm Accessed on 12/11/10